Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trial.

Nunes MC, Cutland CL, Moultrie A, Jones S, Ortiz JR, Neuzil KM, Klugman KP, Simões EAF, Weinberg A, Madhi SA; Maternal Flu Trial Team.

Lancet HIV. 2020 Jan 3. pii: S2352-3018(19)30322-4. doi: 10.1016/S2352-3018(19)30322-4. [Epub ahead of print]

2.

Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal.

Shakya M, Colin-Jones R, Theiss-Nyland K, Voysey M, Pant D, Smith N, Liu X, Tonks S, Mazur O, Farooq YG, Clarke J, Hill J, Adhikari A, Dongol S, Karkey A, Bajracharya B, Kelly S, Gurung M, Baker S, Neuzil KM, Shrestha S, Basnyat B, Pollard AJ; TyVAC Nepal Study Team.

N Engl J Med. 2019 Dec 5;381(23):2209-2218. doi: 10.1056/NEJMoa1905047.

3.

Future epidemiological and economic impacts of universal influenza vaccines.

Sah P, Alfaro-Murillo JA, Fitzpatrick MC, Neuzil KM, Meyers LA, Singer BH, Galvani AP.

Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20786-20792. doi: 10.1073/pnas.1909613116. Epub 2019 Sep 23. Erratum in: Proc Natl Acad Sci U S A. 2019 Oct 29;116(44):22409.

4.

Trivalent influenza vaccination randomized control trial of pregnant women and adverse fetal outcomes.

Simões EAF, Nunes MC, Carosone-Link P, Madimabe R, Ortiz JR, Neuzil KM, Klugman KP, Cutland CL, Madhi SA; Matflu Team.

Vaccine. 2019 Aug 23;37(36):5397-5403. doi: 10.1016/j.vaccine.2019.07.024. Epub 2019 Jul 19.

5.

Maternal immunization in Malawi: A mixed methods study of community perceptions, programmatic considerations, and recommendations for future planning.

Fleming JA, Munthali A, Ngwira B, Kadzandira J, Jamili-Phiri M, Ortiz JR, Lambach P, Hombach J, Neuzil KM, Stepanchak M, Bhat N.

Vaccine. 2019 Jul 26;37(32):4568-4575. doi: 10.1016/j.vaccine.2019.06.020.

6.

Influenza vaccine programs for children in low- and middle-income countries: current status and way forward.

Ortiz JR, Neuzil KM.

Expert Rev Vaccines. 2019 Jul;18(7):711-724. doi: 10.1080/14760584.2019.1635462. Epub 2019 Jul 5.

PMID:
31226895
7.

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study.

Bilcke J, Antillón M, Pieters Z, Kuylen E, Abboud L, Neuzil KM, Pollard AJ, Paltiel AD, Pitzer VE.

Lancet Infect Dis. 2019 Jul;19(7):728-739. doi: 10.1016/S1473-3099(18)30804-1. Epub 2019 May 23.

8.

Reply to Skowronski and De Serres.

Ortiz JR, Sugimoto JD, Neuzil KM, Halloran ME, Victor JC.

Clin Infect Dis. 2019 Nov 27;69(12):2231-2232. doi: 10.1093/cid/ciz352. No abstract available.

PMID:
31056688
9.

A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper.

Laurens MB, Sirima SB, Rotrosen ET, Siribie M, Tiono A, Ouedraogo A, Liang Y, Jamka LP, Kotloff KL, Neuzil KM.

Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S59-S66. doi: 10.1093/cid/ciy1104.

10.

Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.

Theiss-Nyland K, Shakya M, Colin-Jones R, Voysey M, Smith N, Karkey A, Dongol S, Pant D, Farooq YG, Neuzil KM, Shrestha S, Basnyat B, Pollard AJ.

Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S67-S73. doi: 10.1093/cid/ciy1106.

11.

Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives?

Jamka LP, Simiyu KW, Bentsi-Enchill AD, Mwisongo AJ, Matzger H, Marfin AA, Pollard AJ, Neuzil KM.

Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S171-S176. doi: 10.1093/cid/ciy1118.

12.

The Time is Now to Control Typhoid.

Pollard AJ, Marfin AA, Neuzil KM.

Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S47-S49. doi: 10.1093/cid/ciy1115. No abstract available.

13.

Forecasting Demand for the Typhoid Conjugate Vaccine in Low- and Middle-income Countries.

Debellut F, Hendrix N, Pitzer VE, Neuzil KM, Constenla D, Bar-Zeev N, Marfin A, Pecenka C.

Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S154-S160. doi: 10.1093/cid/ciy1076.

14.

Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi.

Meiring JE, Laurens MB, Patel P, Patel P, Misiri T, Simiyu K, Mwakiseghile F, Tracy JK, Masesa C, Liang Y, Henrion M, Rotrosen E, Gmeiner M, Heyderman R, Kotloff K, Gordon MA, Neuzil KM.

Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S50-S58. doi: 10.1093/cid/ciy1103.

15.

Introduction of Typhoid Conjugate Vaccines in Africa and Asia.

Neuzil KM, Pollard AJ, Marfin AA.

Clin Infect Dis. 2019 Feb 15;68(Suppl 1):S27-S30. doi: 10.1093/cid/ciy878.

16.

Impact of Rotavirus Vaccine Introduction in Children Less Than 2 Years of Age Presenting for Medical Care With Diarrhea in Rural Matlab, Bangladesh.

Schwartz LM, Zaman K, Yunus M, Basunia AH, Faruque ASG, Ahmed T, Rahman M, Sugimoto JD, Halloran ME, Rowhani-Rahbar A, Neuzil KM, Victor JC.

Clin Infect Dis. 2019 Nov 27;69(12):2059-2070. doi: 10.1093/cid/ciz133.

17.

Influenza Immunization in Low- and Middle-Income Countries: Preparing for Next-Generation Influenza Vaccines.

Ortiz JR, Neuzil KM.

J Infect Dis. 2019 Apr 8;219(Supplement_1):S97-S106. doi: 10.1093/infdis/jiz024.

PMID:
30715348
18.

The Impact of Influenza Vaccine: It's the Size of the Glass.

Neuzil KM, Fitzpatrick MC.

Clin Infect Dis. 2019 Nov 13;69(11):1854-1855. doi: 10.1093/cid/ciz078. No abstract available.

PMID:
30715260
19.

Effectiveness of Seasonal Influenza Vaccination in Children in Senegal During a Year of Vaccine Mismatch: A Cluster-randomized Trial.

Diallo A, Diop OM, Diop D, Niang MN, Sugimoto JD, Ortiz JR, Faye EHA, Diarra B, Goudiaby D, Lewis KDC, Emery SL, Zangeneh SZ, Lafond KE, Sokhna C, Halloran ME, Widdowson MA, Neuzil KM, Victor JC.

Clin Infect Dis. 2019 Oct 30;69(10):1780-1788. doi: 10.1093/cid/ciz066.

PMID:
30689757
20.

Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh.

Lewis KDC, Ortiz JR, Rahman MZ, Levine MZ, Rudenko L, Wright PF, Katz JM, Dally L, Rahman M, Isakova-Sivak I, Ilyushina NA, Matyushenko V, Fry AM, Lindstrom SE, Bresee JS, Brooks WA, Neuzil KM.

Clin Infect Dis. 2019 Aug 16;69(5):777-785. doi: 10.1093/cid/ciy1003.

21.

The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children.

Brickley EB, Wright PF, Khalenkov A, Neuzil KM, Ortiz JR, Rudenko L, Levine MZ, Katz JM, Brooks WA.

Clin Infect Dis. 2019 Aug 16;69(5):786-794. doi: 10.1093/cid/ciy1004.

22.

Traditional cooking practices and preferences for stove features among women in rural Senegal: Informing improved cookstove design and interventions.

Hooper LG, Dieye Y, Ndiaye A, Diallo A, Sack CS, Fan VS, Neuzil KM, Ortiz JR.

PLoS One. 2018 Nov 20;13(11):e0206822. doi: 10.1371/journal.pone.0206822. eCollection 2018.

23.

Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam.

Thang HV, Huong VM, Victor JC, Van CB, Nga NT, Be LV, Cuong NP, Tsvetnitsky V, Neuzil KM, Power M, Flores J.

Vaccine. 2018 Nov 12;36(46):6918-6925. doi: 10.1016/j.vaccine.2018.10.013. Epub 2018 Oct 15.

PMID:
30337172
24.

Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-naïve children in a randomized clinical trial in rural Senegal.

Diallo A, Victor JC, Feser J, Ortiz JR, Kanesa-Thasan N, Ndiaye M, Diarra B, Cheikh S, Diene D, Ndiaye T, Ndiaye A, Lafond KE, Widdowson MA, Neuzil KM.

Vaccine. 2018 Oct 15;36(43):6424-6432. doi: 10.1016/j.vaccine.2018.08.032. Epub 2018 Sep 14.

25.

Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study.

Chen WH, Neuzil KM, Boyce CR, Pasetti MF, Reymann MK, Martellet L, Hosken N, LaForce FM, Dhere RM, Pisal SS, Chaudhari A, Kulkarni PS, Borrow R, Findlow H, Brown V, McDonough ML, Dally L, Alderson MR.

Lancet Infect Dis. 2018 Oct;18(10):1088-1096. doi: 10.1016/S1473-3099(18)30400-6. Epub 2018 Aug 14.

PMID:
30120069
26.

Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries.

Debellut F, Hendrix N, Ortiz JR, Lambach P, Neuzil KM, Bhat N, Pecenka C.

PLoS One. 2018 Jun 22;13(6):e0199470. doi: 10.1371/journal.pone.0199470. eCollection 2018.

27.

A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands.

Gessner BD, Jiang Q, Van Werkhoven CH, Sings HL, Webber C, Scott D, Neuzil KM, O'Brien KL, Wunderink RG, Grobbee DE, Bonten MJM, Jodar L.

Vaccine. 2019 Sep 10;37(38):5777-5787. doi: 10.1016/j.vaccine.2018.05.097. Epub 2018 May 31.

28.

Implementation of maternal influenza immunization in El Salvador: Experiences and lessons learned from a mixed-methods study.

Fleming JA, Baltrons R, Rowley E, Quintanilla I, Crespin E, Ropero AM, Ortiz JR, Lambach P, Neuzil KM, Stepanchak M, Hombach J, Bhat N.

Vaccine. 2018 Jun 27;36(28):4054-4061. doi: 10.1016/j.vaccine.2018.05.096. Epub 2018 May 30.

PMID:
29859803
29.

How do we best prevent influenza in young children?

Neuzil KM, Rotrosen ET.

Lancet Respir Med. 2018 May;6(5):317-319. doi: 10.1016/S2213-2600(18)30138-3. Epub 2018 Apr 6. No abstract available.

PMID:
29631856
30.

Commentary: Quantifying the Impact of Maternal Influenza Vaccination-Beyond Laboratory-Confirmed Efficacy.

Neuzil KM.

Pediatr Infect Dis J. 2018 May;37(5):441-442. doi: 10.1097/INF.0000000000001967. No abstract available.

PMID:
29485522
31.

Global influenza seasonality to inform country-level vaccine programs: An analysis of WHO FluNet influenza surveillance data between 2011 and 2016.

Newman LP, Bhat N, Fleming JA, Neuzil KM.

PLoS One. 2018 Feb 21;13(2):e0193263. doi: 10.1371/journal.pone.0193263. eCollection 2018.

32.

Maternal influenza immunization in Malawi: Piloting a maternal influenza immunization program costing tool by examining a prospective program.

Pecenka C, Munthali S, Chunga P, Levin A, Morgan W, Lambach P, Bhat N, Neuzil KM, Ortiz JR, Hutubessy R.

PLoS One. 2017 Dec 27;12(12):e0190006. doi: 10.1371/journal.pone.0190006. eCollection 2017.

33.

Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016.

Ortiz JR, Hickling J, Jones R, Donabedian A, Engelhardt OG, Katz JM, Madhi SA, Neuzil KM, Rimmelzwaan GF, Southern J, Spiro DJ, Hombach J.

Vaccine. 2018 Feb 8;36(7):932-938. doi: 10.1016/j.vaccine.2017.11.061. Epub 2017 Dec 6.

34.

Influenza Among Young Children in Bangladesh: Clinical Characteristics and Outcomes From a Randomized Clinical Trial.

Rotrosen E, Zaman K, Feser J, Ortiz JR, Goswami D, Sharmeen AT, Rahman M, Lewis KDC, Rahman MZ, Barin B, Brooks WA, Neuzil KM.

Clin Infect Dis. 2017 Nov 13;65(11):1914-1920. doi: 10.1093/cid/cix674.

35.

Influenza Vaccines for Older Persons: Progress and Pitfalls.

Neuzil KM, Chen WH.

J Infect Dis. 2017 Aug 15;216(4):397-398. doi: 10.1093/infdis/jix285. No abstract available.

PMID:
28931245
36.

Reaching every child with rotavirus vaccine: Report from the 10th African rotavirus symposium held in Bamako, Mali.

Sow SO, Steele AD, Mwenda JM, Armah GE, Neuzil KM.

Vaccine. 2017 Oct 9;35(42):5511-5518. doi: 10.1016/j.vaccine.2017.08.084.

37.

Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines.

Neuzil KM, Bresee JS, de la Hoz F, Johansen K, Karron RA, Krishnan A, Madhi SA, Mangtani P, Spiro DJ, Ortiz JR; WHO Preferred Product Characteristics for Next-Generation Influenza Vaccines Advisory Group.

Vaccine. 2017 Oct 13;35(43):5734-5737. doi: 10.1016/j.vaccine.2017.08.088. Epub 2017 Sep 20.

38.

Incidence of laboratory-confirmed influenza disease among infants under 6 months of age: a systematic review.

Fell DB, Johnson J, Mor Z, Katz MA, Skidmore B, Neuzil KM, Ortiz JR, Bhat N.

BMJ Open. 2017 Sep 7;7(9):e016526. doi: 10.1136/bmjopen-2017-016526. Review. Erratum in: BMJ Open. 2018 Jan 30;8(1):e016526corr1.

39.

Influenza immunization of pregnant women in resource-constrained countries: an update for funding and implementation decisions.

Ortiz JR, Neuzil KM.

Curr Opin Infect Dis. 2017 Oct;30(5):455-462. doi: 10.1097/QCO.0000000000000392. Review.

PMID:
28777109
40.

Influenza: A Global Perspective.

Rotrosen ET, Neuzil KM.

Pediatr Clin North Am. 2017 Aug;64(4):911-936. doi: 10.1016/j.pcl.2017.03.007. Review.

PMID:
28734518
41.

Efficacy of Maternal Influenza Vaccination Against All-Cause Lower Respiratory Tract Infection Hospitalizations in Young Infants: Results From a Randomized Controlled Trial.

Nunes MC, Cutland CL, Jones S, Downs S, Weinberg A, Ortiz JR, Neuzil KM, Simões EAF, Klugman KP, Madhi SA.

Clin Infect Dis. 2017 Oct 1;65(7):1066-1071. doi: 10.1093/cid/cix497.

42.

Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial.

Zaman K, Sack DA, Neuzil KM, Yunus M, Moulton LH, Sugimoto JD, Fleming JA, Hossain I, Arifeen SE, Azim T, Rahman M, Lewis KDC, Feller AJ, Qadri F, Halloran ME, Cravioto A, Victor JC.

PLoS Med. 2017 Apr 18;14(4):e1002282. doi: 10.1371/journal.pmed.1002282. eCollection 2017 Apr.

43.

Contribution of Serologic Assays in the Evaluation of Influenza Virus Infection Rates and Vaccine Efficacy in Pregnant Women: Report From Randomized Controlled Trials.

Madhi SA, Nunes MC, Weinberg A, Kuwanda L, Hugo A, Jones S, van Niekerk N, Ortiz JR, Neuzil KM, Klugman KP, Simões EAF, Cutland CL; Maternal Flu Trial (Matflu) Team.

Clin Infect Dis. 2017 Jun 15;64(12):1773-1779. doi: 10.1093/cid/cix241.

44.

Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study.

Somayaji R, Goss CH, Khan U, Neradilek M, Neuzil KM, Ortiz JR.

Clin Infect Dis. 2017 Jun 15;64(12):1760-1767. doi: 10.1093/cid/cix203.

45.

Effect of human rotavirus vaccine on severe diarrhea in African infants.

Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, Han HH, Neuzil KM.

Malawi Med J. 2016 Sep;28(3):108-114.

46.

Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design.

Schwartz LM, Halloran ME, Rowhani-Rahbar A, Neuzil KM, Victor JC.

Vaccine. 2017 Jan 3;35(1):184-190. doi: 10.1016/j.vaccine.2016.10.077. Epub 2016 Nov 18.

47.

Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial.

Brooks WA, Zaman K, Lewis KD, Ortiz JR, Goswami D, Feser J, Sharmeen AT, Nahar K, Rahman M, Rahman MZ, Barin B, Yunus M, Fry AM, Bresee J, Azim T, Neuzil KM.

Lancet Glob Health. 2016 Dec;4(12):e946-e954. doi: 10.1016/S2214-109X(16)30200-5. Epub 2016 Oct 13.

48.

Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial.

Victor JC, Lewis KD, Diallo A, Niang MN, Diarra B, Dia N, Ortiz JR, Widdowson MA, Feser J, Hoagland R, Emery SL, Lafond KE, Neuzil KM.

Lancet Glob Health. 2016 Dec;4(12):e955-e965. doi: 10.1016/S2214-109X(16)30201-7. Epub 2016 Oct 13.

49.

Preventing Shingles and Its Complications in Older Persons.

Neuzil KM, Griffin MR.

N Engl J Med. 2016 Sep 15;375(11):1079-80. doi: 10.1056/NEJMe1610652. No abstract available.

PMID:
27626522
50.

Estimating pediatric asthma prevalence in rural senegal: A cross-sectional survey.

Hooper LG, Dieye Y, Ndiaye A, Diallo A, Fan VS, Neuzil KM, Ortiz JR.

Pediatr Pulmonol. 2017 Mar;52(3):303-309. doi: 10.1002/ppul.23545. Epub 2016 Aug 23.

PMID:
27551858

Supplemental Content

Loading ...
Support Center